Global "In
Vitro Diagnostics (IVD) Quality Control Market" 2024 Industry research report covers the industry overview with
Marketplace Size, Share, Development, futuristic cost, earnings, demand and
distribution data. Its vast repository offers an analytical summary of the
marketplace that can help to the new and existing player to take a significant
decision.
In this report, we
thoroughly examine and analyse the Global market for In Vitro Diagnostics (IVD)
Quality Control so that market participants can improve their business strategy
and ensure long-term success. This report provides players with useful
information and suggests result-based ideas to give them a competitive
advantage in the global In Vitro Diagnostics (IVD) Quality Control industry. It
will show how other players compete in the global In Vitro Diagnostics (IVD)
Quality Control Market and explain the strategies you use to differentiate
yourself from other participants.
Download Free Sample
Report Now @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sample
Industry Insights
The global In Vitro
Diagnostics (IVD) Quality Control Market is anticipated to reach USD 1.13
billion by 2024. The rising number of certified clinical laboratories requires
quality control (QC) services to maintain their standards, associated with the
increasing acceptance of third party providers of quality control services, to
ensure the accurate and reproducible test results, and better outcomes which is
anticipated to drive the growth.
For the establishment of
definite standards of quality, the internal Quality Control (QC) programs and
the external QAS (Quality Assurance Schemes) is very important to ensure
validity and reliability of the test results obtained by the IVD devices. These
programs are essential in confirming the delivery of patient diagnostic
outcomes, which are reliable and without errors, such as misdiagnosis because
of device-related errors, which can impact the health of the patient.
The regulation of these In
vitro diagnostics devices are controlled by the respective regulatory bodies,
which includes the U.S. FDA (Food and Drug Administration), the International
Medical Device Regulators Forum (IMDRF), the European Commission, the
Australian Therapeutic Goods Administration (TGA), the Eurasian Economic Union
(EEU) and the Brazilian National Health Surveillance Agency (ANVISA).
The currently undergoing,
extensive R&D related activities beside the introduction of new laws with
the aim of improving the efficacy and safety levels of the IVD services are
anticipated to drive market growth. For example, in September 2012, a new
regulation for IVD devices was published by the European Commission targeted to
enhance the transparency, safety and the traceability without constraining
innovation. These new regulatory inclusions are anticipated to drive the market
growth.
Application Insights
There are numerous
applications of the IVDs, which includes haematology, immunology, coagulation,
clinical chemistry, molecular diagnostics and microbiology. Amongst these all,
molecular diagnostics is anticipated to be the fastest growing market segment
with 4.88% CAGR. The frequent usage of the technologies in the molecular
diagnostics, such as gene expression and PCR, high accuracy and specificity are
some of the responsible factors associated with its high growth.
End-use Insights
The hospitals market
segment was valued the largest market segment of over 46.0% in 2016 owing to
the high application of IVD tests in hospitals and the necessity of obedience
with the IVD directives for the product traceability. The home care market
segment is anticipated to observe a lucrative progression owing to the
persistent increase in the usage devices for point-of-care testing. The rise in
adoption of microchip technology which is used to handle fluids in IVD
equipment, as well as the enhanced production processes and the miniaturization
technology are creating efficient point-of-care devices, which are very less
susceptible to errors.
Regional Insights
In 2016, largest market
share of the IVD quality control market was found to be of North America with
revenue of approximately USD over 400.0 million. The existence of a huge number
of qualified clinical laboratories, a good distribution network and the rising
number of IVD products approvals having assured safety and quality from the
regulatory authorities are some of the major driving factors.
The Asia Pacific region had
the highest CAGR of over 4.8% owing to the rising government efforts for the
standardization of the testing procedures of the clinical laboratory to improve
accuracy of results.
Competitive Market Share
Insights
Some major key players of
the IVD quality control market includes Siemens Healthcare GmbH, Alere, Inc.,
Roche Diagnostics, Abbott Laboratories, Inc., Qiagen N.V., Hologic, Inc. (Gen-Probe),
Bio-Rad Laboratories, Inc., Becton, Dickinson and Company(BD), Quidel
Corporation, bioMerieux, Inc., Thermo Fisher Scientific, Inc., Sero AS and
Sysmex Corporation.
Know
More Insights @ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment